Hualan Biological Vaccine Inc. (SHE:301207)
China · Delayed Price · Currency is CNY 17.22
-0.48 (-2.71%)
Sep 11, 2026, 3:04 PM CST
Hualan Biological Vaccine Market Cap
Hualan Biological Vaccine has a market cap or net worth of 10.25 billion as of September 11, 2026. Its market cap has decreased by -6.06% in one year.
Market Cap
10.25B
Enterprise Value
8.09B
Revenue
1.19B
Ranking
n/a
PE Ratio
51.66
Stock Price
17.22
ChartMarket Cap Chart
Since February 18, 2022, Hualan Biological Vaccine's market cap has decreased from 28.12B to 10.25B, a decrease of -63.56%. That is a compound annual growth rate of -19.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 10.25B | -7.57% |
| Dec 31, 2025 | 11.08B | 6.40% |
| Dec 31, 2024 | 10.42B | -37.54% |
| Dec 29, 2023 | 16.68B | -6.46% |
| Dec 30, 2022 | 17.83B | -36.59% |
| Feb 18, 2022 | 28.12B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shanghai Medicilon | 12.33B |
| Sino Biological,Inc. | 12.12B |
| Inner Mongolia Furui Medical Science | 11.73B |
| Chengzhi | 11.50B |
| Tibet Cheezheng Tibetan Medicine | 11.46B |
| Chengdu Olymvax Biopharmaceuticals | 11.43B |
| Mabwell (Shanghai) Bioscience | 11.43B |
| InventisBio | 11.36B |